Strs Ohio Catalyst Pharmaceuticals, Inc. Transaction History

Strs Ohio

$24.9 Billion
Q2 2024

A detailed history of Strs Ohio transactions in Catalyst Pharmaceuticals, Inc. stock. As of the latest transaction made, Strs Ohio holds 51,200 shares of CPRX stock, worth $1 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

51,200

Previous 48,300 6.0%

Holding current value

$1 Million

Previous $769,000 3.12%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 05, 2024	BUY	$14.68 - $16.92 $42,572 - $49,068	2,900 Added 6.0%	51,200 $793,000
Q1 2024 May 13, 2024	SELL	$13.18 - $17.11 $102,804 - $133,458	-7,800 Reduced 13.9%	48,300 $769,000
Q4 2023 Jan 30, 2024	SELL	$11.78 - $17.29 $36,518 - $53,599	-3,100 Reduced 5.24%	56,100 $943,000
Q2 2023 Jul 31, 2023	BUY	$11.5 - $18.08 $79,350 - $124,751	6,900 Added 13.19%	59,200 $795,000
Q1 2023 Aug 02, 2023	SELL	$14.34 - $21.05 $98,946 - $145,245	-6,900 Reduced 11.66%	52,300 $867,000
Q1 2023 Apr 27, 2023	BUY	$14.34 - $21.05 $51,624 - $75,780	3,600 Added 7.39%	52,300 $867,000
Q4 2022 Jan 26, 2023	SELL	$12.25 - $19.5 $167,825 - $267,150	-13,700 Reduced 21.96%	48,700 $905,000
Q3 2022 Oct 27, 2022	SELL	$7.06 - $15.52 $283,106 - $622,352	-40,100 Reduced 39.12%	62,400 $800,000
Q2 2022 Jul 25, 2022	SELL	$6.23 - $8.57 $13,706 - $18,854	-2,200 Reduced 2.1%	102,500 $718,000
Q1 2022 Apr 21, 2022	SELL	$5.31 - $8.31 $117,350 - $183,651	-22,100 Reduced 17.43%	104,700 $867,000
Q4 2021 Jan 24, 2022	SELL	$5.21 - $7.45 $172,972 - $247,340	-33,200 Reduced 20.75%	126,800 $858,000
Q3 2021 Oct 22, 2021	BUY	$4.85 - $6.04 $80,025 - $99,660	16,500 Added 11.5%	160,000 $848,000
Q2 2021 Jul 26, 2021	SELL	$4.29 - $6.05 $220,077 - $310,365	-51,300 Reduced 26.33%	143,500 $825,000
Q1 2021 Apr 23, 2021	BUY	$3.45 - $4.69 $51,750 - $70,350	15,000 Added 8.34%	194,800 $898,000
Q4 2020 Jan 25, 2021	BUY	$2.97 - $3.83 $35,937 - $46,343	12,100 Added 7.22%	179,800 $600,000
Q3 2020 Dec 14, 2020	BUY	$2.97 - $5.08 $135,432 - $231,648	45,600 Added 37.35%	167,700 $498,000
Q2 2020 Jul 23, 2020	SELL	$3.48 - $5.05 $93,960 - $136,350	-27,000 Reduced 18.11%	122,100 $564,000
Q4 2019 Jan 24, 2020	BUY	$3.67 - $5.7 $107,164 - $166,440	29,200 Added 24.35%	149,100 $559,000
Q3 2019 Oct 21, 2019	SELL	$3.89 - $7.43 $189,054 - $361,098	-48,600 Reduced 28.84%	119,900 $636,000
Q2 2019 Jul 25, 2019	SELL	$2.7 - $6.11 $59,670 - $135,031	-22,100 Reduced 11.59%	168,500 $647,000
Q3 2018 Oct 19, 2018	SELL	$2.81 - $3.78 $91,325 - $122,850	-32,500 Reduced 14.57%	190,600 $720,000
Q1 2018 Apr 20, 2018	BUY	$2.39 - $4.01 $143,639 - $241,001	60,100 Added 36.87%	223,100 $533,000
Q4 2017 Jan 23, 2018	BUY	$2.51 - $4.4 $409,129 - $717,200	163,000	163,000 $637,000

Others Institutions Holding CPRX

# of Institutions

285

Shares Held

96.6M

Call Options Held

29.2K

Put Options Held

20.5K

View Full List

About CATALYST PHARMACEUTICALS, INC.

Ticker CPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 102,820,000
Market Cap $2.01B
Description
Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...

More about CPRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

News

Stay updated on Strs Ohio with notifications on news.

Account